Both in Pharmaceuticals
UroGen Pharma vs Nuvation Bio
Over the past year URGN returned +111.3% and NUVB returned +74.5%; their daily moves had a correlation of 0.34.
URGN +111.3% NUVB +74.5%Growth of $1, one year, split-adjusted
| Metric | URGN | NUVB |
|---|---|---|
| Price | $40.45 | $5.62 |
| Market cap | $1.98B | $1.97B |
| Today | −1.10% | +0.36% |
| 1 month | −7.3% | −15.6% |
| 6 months | +137.9% | +38.8% |
| Year to date | +72.7% | −37.3% |
| 1 year | +120.6% | +75.6% |
| Revenue growth (YoY) | +199.2% | +555.6% |
| Gross margin | 90.9% | 73.0% |
| Net margin | −19.8% | −198.3% |
| P/E (TTM) | — | — |
| Price / sales | 10.5× | 11.6× |
| Net cash | -$85.1M | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | 52.3% | 54.8% |
| Short % of float | 13.7% | 22.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).